Skip to content

Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure

Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02766283
Enrollment
843
Registered
2016-05-09
Start date
2016-06-30
Completion date
2016-08-30
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypothyroidism

Keywords

Children, Iodinated contrast agents

Brief summary

To investigate the incidence of detected hypothyroidism after iodinated contrast exposure in pediatric patients from birth to 3 years of age (inclusive) in a routine clinical practice setting.

Interventions

Intravascular application

Sponsors

Bayer
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 3 Years
Healthy volunteers
No

Inclusion criteria

\- All children age 0-3 years (inclusive) who are identified of having undergone a radiological examination with intravascular use of an iodinated contrast agent.(e.g. contrast enhanced CT, cardioangiography)

Exclusion criteria

* Congenital Hypothyroidism or other forms of preexisting hypothyroidism * Preexisting thyroid hormone replacement therapy less than three months of observation before the radiological examination (if greater than three months old) * Less than two weeks follow-up available after the contrast exposure.

Design outcomes

Primary

MeasureTime frame
Number of Pediatric Patients With Detected Hypothyroidism After Iodinated Contrast Exposure in a Routine Clinical Practice SettingUp to one year after iodinated contrast material (ICM) exposure (828 person years)

Secondary

MeasureTime frameDescription
Baseline Characteristics (Age) of the Cases With Hypothyroidism and of the Rest of the CohortAt first examination
Baseline Characteristics (Weight) of the Cases With Hypothyroidism and of the Rest of the CohortWithin a range of ±360 days of the first examination
Baseline Characteristics (Comorbidity) of the Cases With Hypothyroidism and of the Rest of the CohortPrior to first examination
Baseline Characteristics (Sum of Examinations) in Cases With an Indication of Hypothyroidism and Cases WithoutUp to one year after ICM exposure (828 person years)
Baseline Characteristics (Sex) of the Cases With Hypothyroidism and of the Rest of the CohortUp to one year after ICM exposure (828 person years)
Baseline Characteristics (Type of 2nd Examination) in Cases With an Indication of Hypothyroidism and Cases WithoutUp to one year after ICM exposure (828 person years)
Baseline Characteristics (Time Between Examinations) in Cases With an Indication of Hypothyroidism and Cases WithoutUp to one year after ICM exposure (828 person years)
Time-relation Between Iodine Contrast Exposure and Diagnosis of HypothyroidismUp to one year after ICM exposure (828 person years)
The Duration of Hypothyroidism Episode in the Probable Iodine Induced CategoryUp to one year after ICM exposure (828 person years)Based on the information collected from the database, the probable longest duration of Hypothyroidism was ascertained for the cases below.
Baseline Characteristics (Type of 1st Examination) in Cases With an Indication of Hypothyroidism and Cases WithoutUp to one year after ICM exposure (828 person years)

Countries

Israel

Participant flow

Recruitment details

This study was a retrospective cohort study, using the data from the years 1998 until 2015 in the database of Maccabi Health Services (Israel).

Pre-assignment details

Between 1.1.1998 and 31.12.2015, 877 participants were identified. After applying exclusion criteria, 34 participants were excluded from the initial cohort and the final cohort consisted of 843 participants.

Participants by arm

ArmCount
Iodine Contrast Agent
The data used for this retrospective cohort study was from the years 1998 until 2015. The study population consisted of children ages 0-3 (inclusive) who have undergone a radiological examination with an iodinated contrast agent (contrast enhanced CT and cardio-angiography). Follow-up for the outcome (hypothyroidism) was for up to one year after contrast exposure. Incident cases of hypothyroidism were detected by: TSH levels, coded diagnosis of hypothyroidism or start of new thyroid replacement therapy.
843
Total843

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up27

Baseline characteristics

CharacteristicIodine Contrast Agent
Age, Continuous1.06 Years
STANDARD_DEVIATION 0.87
Comorbidity
Cancer
21 Participants
Comorbidity
Cardio
495 Participants
Comorbidity
Diabetes
1 Participants
Comorbidity
Overweight
12 Participants
Dispenses of hypothyroidism inducing drugs
Amiodarone
5 Participants
Dispenses of hypothyroidism inducing drugs
Anticonvulsants
21 Participants
Sex: Female, Male
Female
382 Participants
Sex: Female, Male
Male
461 Participants
Sum of Examinations
1
775 Participants
Sum of Examinations
>= 2
68 Participants
Time between examinations
First and second
282.79 Days
STANDARD_DEVIATION 252.34
Time between examinations
Second and third
208.19 Days
STANDARD_DEVIATION 180.01
Time between examinations
Third and fourth
212.00 Days
STANDARD_DEVIATION 196.28
Type of 1st examination
Cardio-angiography
481 Participants
Type of 1st examination
CT
362 Participants
Type of >=2nd examination
Cardio-angiography
47 Participants
Type of >=2nd examination
CT
21 Participants
Weight8.80 Kilograms
STANDARD_DEVIATION 3.39

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

Primary

Number of Pediatric Patients With Detected Hypothyroidism After Iodinated Contrast Exposure in a Routine Clinical Practice Setting

Time frame: Up to one year after iodinated contrast material (ICM) exposure (828 person years)

Population: Final Cohort

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Iodine Contrast AgentNumber of Pediatric Patients With Detected Hypothyroidism After Iodinated Contrast Exposure in a Routine Clinical Practice Setting11 Participants
Secondary

Baseline Characteristics (Age) of the Cases With Hypothyroidism and of the Rest of the Cohort

Time frame: At first examination

Population: Final Cohort

ArmMeasureValue (MEAN)Dispersion
Iodine Contrast AgentBaseline Characteristics (Age) of the Cases With Hypothyroidism and of the Rest of the Cohort1.07 YearsStandard Deviation 0.86
Hypothyroidism IndicationBaseline Characteristics (Age) of the Cases With Hypothyroidism and of the Rest of the Cohort0.53 YearsStandard Deviation 0.96
Secondary

Baseline Characteristics (Comorbidity) of the Cases With Hypothyroidism and of the Rest of the Cohort

Time frame: Prior to first examination

Population: Final Cohort

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Iodine Contrast AgentBaseline Characteristics (Comorbidity) of the Cases With Hypothyroidism and of the Rest of the CohortCardio485 Participants
Iodine Contrast AgentBaseline Characteristics (Comorbidity) of the Cases With Hypothyroidism and of the Rest of the CohortDiabetes1 Participants
Iodine Contrast AgentBaseline Characteristics (Comorbidity) of the Cases With Hypothyroidism and of the Rest of the CohortCancer21 Participants
Iodine Contrast AgentBaseline Characteristics (Comorbidity) of the Cases With Hypothyroidism and of the Rest of the CohortOverweight12 Participants
Hypothyroidism IndicationBaseline Characteristics (Comorbidity) of the Cases With Hypothyroidism and of the Rest of the CohortOverweight0 Participants
Hypothyroidism IndicationBaseline Characteristics (Comorbidity) of the Cases With Hypothyroidism and of the Rest of the CohortCardio10 Participants
Hypothyroidism IndicationBaseline Characteristics (Comorbidity) of the Cases With Hypothyroidism and of the Rest of the CohortCancer0 Participants
Hypothyroidism IndicationBaseline Characteristics (Comorbidity) of the Cases With Hypothyroidism and of the Rest of the CohortDiabetes0 Participants
Secondary

Baseline Characteristics (Sex) of the Cases With Hypothyroidism and of the Rest of the Cohort

Time frame: Up to one year after ICM exposure (828 person years)

Population: Final Cohort

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Iodine Contrast AgentBaseline Characteristics (Sex) of the Cases With Hypothyroidism and of the Rest of the CohortMale454 Participants
Iodine Contrast AgentBaseline Characteristics (Sex) of the Cases With Hypothyroidism and of the Rest of the CohortFemale378 Participants
Hypothyroidism IndicationBaseline Characteristics (Sex) of the Cases With Hypothyroidism and of the Rest of the CohortMale7 Participants
Hypothyroidism IndicationBaseline Characteristics (Sex) of the Cases With Hypothyroidism and of the Rest of the CohortFemale4 Participants
Secondary

Baseline Characteristics (Sum of Examinations) in Cases With an Indication of Hypothyroidism and Cases Without

Time frame: Up to one year after ICM exposure (828 person years)

Population: Final Cohort

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Iodine Contrast AgentBaseline Characteristics (Sum of Examinations) in Cases With an Indication of Hypothyroidism and Cases Without1765 Participants
Iodine Contrast AgentBaseline Characteristics (Sum of Examinations) in Cases With an Indication of Hypothyroidism and Cases Without>=267 Participants
Hypothyroidism IndicationBaseline Characteristics (Sum of Examinations) in Cases With an Indication of Hypothyroidism and Cases Without110 Participants
Hypothyroidism IndicationBaseline Characteristics (Sum of Examinations) in Cases With an Indication of Hypothyroidism and Cases Without>=21 Participants
p-value: 0.9Chi-squared
Secondary

Baseline Characteristics (Time Between Examinations) in Cases With an Indication of Hypothyroidism and Cases Without

Time frame: Up to one year after ICM exposure (828 person years)

Population: Final Cohort

ArmMeasureGroupValue (MEAN)Dispersion
Iodine Contrast AgentBaseline Characteristics (Time Between Examinations) in Cases With an Indication of Hypothyroidism and Cases WithoutSecond and third208.19 DaysStandard Deviation 180.01
Iodine Contrast AgentBaseline Characteristics (Time Between Examinations) in Cases With an Indication of Hypothyroidism and Cases WithoutThird and fourth212.00 DaysStandard Deviation 196.28
Iodine Contrast AgentBaseline Characteristics (Time Between Examinations) in Cases With an Indication of Hypothyroidism and Cases WithoutFirst and second282.72 DaysStandard Deviation 254.24
Hypothyroidism IndicationBaseline Characteristics (Time Between Examinations) in Cases With an Indication of Hypothyroidism and Cases WithoutFirst and second288 Days
Secondary

Baseline Characteristics (Type of 1st Examination) in Cases With an Indication of Hypothyroidism and Cases Without

Time frame: Up to one year after ICM exposure (828 person years)

Population: Final Cohort

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Iodine Contrast AgentBaseline Characteristics (Type of 1st Examination) in Cases With an Indication of Hypothyroidism and Cases WithoutCardio-angiography471 Participants
Iodine Contrast AgentBaseline Characteristics (Type of 1st Examination) in Cases With an Indication of Hypothyroidism and Cases WithoutCT361 Participants
Hypothyroidism IndicationBaseline Characteristics (Type of 1st Examination) in Cases With an Indication of Hypothyroidism and Cases WithoutCardio-angiography10 Participants
Hypothyroidism IndicationBaseline Characteristics (Type of 1st Examination) in Cases With an Indication of Hypothyroidism and Cases WithoutCT1 Participants
p-value: 0.022Chi-squared
Secondary

Baseline Characteristics (Type of 2nd Examination) in Cases With an Indication of Hypothyroidism and Cases Without

Time frame: Up to one year after ICM exposure (828 person years)

Population: Final Cohort

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Iodine Contrast AgentBaseline Characteristics (Type of 2nd Examination) in Cases With an Indication of Hypothyroidism and Cases WithoutCardio-angiography46 Participants
Iodine Contrast AgentBaseline Characteristics (Type of 2nd Examination) in Cases With an Indication of Hypothyroidism and Cases WithoutCT21 Participants
Hypothyroidism IndicationBaseline Characteristics (Type of 2nd Examination) in Cases With an Indication of Hypothyroidism and Cases WithoutCardio-angiography1 Participants
Hypothyroidism IndicationBaseline Characteristics (Type of 2nd Examination) in Cases With an Indication of Hypothyroidism and Cases WithoutCT0 Participants
Secondary

Baseline Characteristics (Weight) of the Cases With Hypothyroidism and of the Rest of the Cohort

Time frame: Within a range of ±360 days of the first examination

Population: Final Cohort

ArmMeasureValue (MEAN)Dispersion
Iodine Contrast AgentBaseline Characteristics (Weight) of the Cases With Hypothyroidism and of the Rest of the Cohort8.84 KilogramsStandard Deviation 3.37
Hypothyroidism IndicationBaseline Characteristics (Weight) of the Cases With Hypothyroidism and of the Rest of the Cohort6.57 KilogramsStandard Deviation 3.74
Secondary

The Duration of Hypothyroidism Episode in the Probable Iodine Induced Category

Based on the information collected from the database, the probable longest duration of Hypothyroidism was ascertained for the cases below.

Time frame: Up to one year after ICM exposure (828 person years)

Population: Probable iodine-induced hypothyroidism: (N=8) included all potential cases of hypothyroidism with no other cause than the previous ICM exposure could be identified.

ArmMeasureGroupValue (NUMBER)
Iodine Contrast AgentThe Duration of Hypothyroidism Episode in the Probable Iodine Induced CategoryCase number 2NA Months
Iodine Contrast AgentThe Duration of Hypothyroidism Episode in the Probable Iodine Induced CategoryCase number 32 Months
Iodine Contrast AgentThe Duration of Hypothyroidism Episode in the Probable Iodine Induced CategoryCase number 6NA Months
Iodine Contrast AgentThe Duration of Hypothyroidism Episode in the Probable Iodine Induced CategoryCase number 102 Months
Secondary

The Duration of Hypothyroidism Episode in the Probable Iodine Induced Category

Based on the information collected from the database, the probable shortest duration of Hypothyroidism was ascertained for the cases below.

Time frame: Up to one year after ICM exposure (828 person years)

Population: Probable iodine-induced hypothyroidism: (N=8) included all potential cases of hypothyroidism with no other cause than the previous ICM exposure could be identified.

ArmMeasureGroupValue (NUMBER)
Iodine Contrast AgentThe Duration of Hypothyroidism Episode in the Probable Iodine Induced CategoryCase number 44 Months
Iodine Contrast AgentThe Duration of Hypothyroidism Episode in the Probable Iodine Induced CategoryCase number 710 Months
Secondary

The Duration of Hypothyroidism Episode in the Probable Iodine Induced Category

Based on the information collected from the database, the probable shortest duration of Hypothyroidism was ascertained for the cases below.

Time frame: Up to one year after ICM exposure (828 person years)

Population: Probable iodine-induced hypothyroidism: (N=8) included all potential cases of hypothyroidism with no other cause than the previous ICM exposure could be identified.

ArmMeasureGroupValue (NUMBER)
Iodine Contrast AgentThe Duration of Hypothyroidism Episode in the Probable Iodine Induced CategoryCase number 514 Days
Iodine Contrast AgentThe Duration of Hypothyroidism Episode in the Probable Iodine Induced CategoryCase number 118 Days
Secondary

Time-relation Between Iodine Contrast Exposure and Diagnosis of Hypothyroidism

Time frame: Up to one year after ICM exposure (828 person years)

Population: Final Cohort

ArmMeasureValue (MEAN)Dispersion
Iodine Contrast AgentTime-relation Between Iodine Contrast Exposure and Diagnosis of Hypothyroidism76.54 DaysStandard Deviation 93.05

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026